Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$47.76 USD
+0.81 (1.73%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $47.85 +0.09 (0.19%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Exact Sciences Corporation has a market cap of $8.86B, which represents its share price of $46.95 multiplied by its outstanding shares number of 188.64M. As a mid-cap company, EXAS's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
EXAS 47.76 +0.81(1.73%)
Will EXAS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EXAS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EXAS
Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect
Will Healthcare Growth Help STE Beat on Q1 Earnings?
EXAS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Perrigo to Report Q2 Earnings: What's in Store for the Stock?
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Charles River Q2 Earnings Preview: What's in Store for the Stock?
Other News for EXAS
Earnings week ahead: AMD, PLTR, PFE, DIS, O, ET, SHOP, GILD, MCD, CAT, VTRS, BP, UBER, CGC, and more
EXAS September 12th Options Begin Trading
Exact Sciences expands colorectal cancer screening partnership with Humana
Baron Discovery Fund Q2 2025 Commentary